Rotavirus epidemiology and surveillance before vaccine introduction in Argentina, 2012-2014

Juan Ignacio Degiuseppe1, Ezequiel Agustín Reale1, Juan Andrés Stupka1

  • 1Laboratorio de Gastroenteritis Virales, Instituto Nacional de Enfermedades Infecciosas (INEI-ANLIS "Dr. Carlos G. Malbrán"), Ciudad Autónoma de Buenos Aires, Argentina.

Insights

Group A Rotavirus is a major cause of infant diarrhea in Argentina. This study details the pre-vaccine genotypes, seasonality, and prevalence patterns observed between 2012-2014.

Area of Science:

  • Virology
  • Public Health
  • Epidemiology

Background:

  • Group A Rotavirus is a leading cause of severe infantile diarrhea globally.
  • In Argentina, it causes over 200,000 diarrhea cases and 30-50 deaths annually in children under five.
  • Understanding pre-vaccine rotavirus epidemiology is crucial for public health interventions.

Purpose of the Study:

  • To analyze the frequency, seasonality, age distribution, and circulating genotypes of Group A Rotavirus in Argentina.
  • To establish a baseline of rotavirus epidemiology prior to vaccine introduction in 2015.
  • To characterize the pre-vaccine scenario for rotavirus in the Argentine population.

Main Methods:

  • Data collected from the Viral Diarrhea Notification module of the Argentine SNVS-SIVILA surveillance tool (2012-2014).
  • Rotavirus-positive stool specimens analyzed for circulating genotypes using conventional binary characterization of capsid genes.
  • Epidemiological data analyzed for frequency, seasonality, and age distribution.

Main Results:

  • Rotavirus was detected in approximately 25% of tested samples, with higher prevalence in children under two years.
  • A distinct winter seasonality pattern was observed, alongside heterogeneous regional prevalence, particularly in the North.
  • Commonly detected genotypes included G1P[8], G2P[4], G3P[8], and G12P[8], with evidence of co-circulation and annual fluctuations.

Conclusions:

  • The study provides a comprehensive overview of the pre-vaccine rotavirus landscape in Argentina.
  • Identified genotypes and epidemiological patterns serve as a critical baseline for post-vaccine surveillance.
  • Findings are essential for evaluating the impact of rotavirus vaccination programs in the region.